After Tregs depletion, tumor formation was attenuated in CCL17 TG mice compared with that in WT mice depleted of Tregs, suggesting that the decrease in MDSCs in a high level of CCL17 may positively contribute to tumor immunity in the absence of Tregs. The gene discussed is CCL17; the disease is neoplasm.